Lindsay J. Bawden

Inhibition of the metastatic spread and growth of B16‐BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor

Renato G. S. Chirvi, Angela Garofalo, M Crimmin et al. · International Journal of Cancer · 1994 · 219 citations

Medicine, Oncology, Pharmacology +17

CHR-2797: An Antiproliferative Aminopeptidase Inhibitor that Leads to Amino Acid Deprivation in Human Leukemic Cells

David Krige, Lindsey Needham, Lindsay J. Bawden et al. · Cancer Research · 2008 · 117 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Discovery of 2-(6-{[(6-Fluoroquinolin-2-yl)methyl]amino}bicyclo[3.1.0]hex-3-yl)-<i>N</i>-hydroxypyrimidine-5-carboxamide (CHR-3996), a Class I Selective Orally Active Histone Deacetylase Inhibitor

David Moffat, Sanjay R. Patel, Francesca A. Day et al. · Journal of Medicinal Chemistry · 2010 · 83 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Cell-targeted PD-1 agonists that mimic PD-L1 are potent T cell inhibitors

Adam P. Curnock, Giovanna Bossi, Jyothi Kumaran et al. · JCI Insight · 2021 · 79 citations · Full text

Life Sciences, Immunology, Medicinal Chemistry +17

BB-10010: an active variant of human macrophage inflammatory protein-1 alpha with improved pharmaceutical properties

MG Hunter, Lindsay J. Bawden, Deborah H. Brotherton et al. · Blood · 1995 · 71 citations · Full text

Life Sciences, Immunology, Pharmacology +10